Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life--the infectious bite preempts these hazards.

J Kevin Baird
Author Information

Abstract

The maxim 'an ounce of prevention is worth a pound of cure' finds few better demonstrations than with malaria caused by Plasmodium vivax. Thoroughly neglected over the past 60 years, the chemotherapy of this complex infection has been dangerous and ineffective until the present. Work is at last being done, but seeing that translate to real improvements at the periphery of care delivery will take years of deliberate effort. In the meantime, patients face substantial risk of debilitating, threatening, and fatal courses of illness associated with a diagnosis of vivax malaria. For some of the most vulnerable to such outcomes--pregnant women and infants--repeated attacks of acute vivax malaria from a single infectious anopheline bite is now not preventable. One of the few measures than can be immediately applied with rigor is vector control, thereby effectively preventing as many of these difficult and dangerous infections as possible. This commentary emphasizes the dire consequences of infection by P. vivax and the real difficulty of dealing with them. That, in turn, emphasizes the many benefits to be derived by preventing them in the first place.

Keywords

References

  1. Malar J. 2011 Oct 11;10:297 [PMID: 21989376]
  2. Lancet Infect Dis. 2012 May;12(5):388-96 [PMID: 22169409]
  3. PLoS One. 2012;7(4):e35406 [PMID: 22523591]
  4. Clin Infect Dis. 2008 May 1;46(9):1374-81 [PMID: 18419439]
  5. Clin Infect Dis. 2009 Jun 15;48(12):1704-12 [PMID: 19438395]
  6. Lancet. 2008 Jan 5;371(9606):64-74 [PMID: 18177777]
  7. Clin Microbiol Rev. 2009 Jul;22(3):508-34 [PMID: 19597012]
  8. PLoS Med. 2010 Jun 15;7(6):e1000290 [PMID: 20563310]
  9. Malar J. 2012 Apr 27;11:135 [PMID: 22540175]
  10. Bull World Health Organ. 1975;52(1):21-32 [PMID: 764993]
  11. Malar J. 2013 Mar 27;12:112 [PMID: 23537118]
  12. Clin Infect Dis. 2011 Mar 1;52(5):612-20 [PMID: 21292666]
  13. Lancet Infect Dis. 2010 Jun;10(6):405-16 [PMID: 20510281]
  14. Clin Microbiol Rev. 2013 Jan;26(1):36-57 [PMID: 23297258]
  15. Ann Intern Med. 1997 Jun 15;126(12):963-72 [PMID: 9182474]
  16. PLoS Med. 2012;9(11):e1001339 [PMID: 23152723]
  17. Pharmacol Rep. 2007 Nov-Dec;59(6):734-8 [PMID: 18195464]
  18. N Engl J Med. 2013 Oct 3;369(14):1381-2 [PMID: 24088113]
  19. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79-87 [PMID: 18165478]
  20. Antimicrob Agents Chemother. 2013 Mar;57(3):1128-35 [PMID: 23254437]
  21. PLoS Negl Trop Dis. 2012;6(9):e1814 [PMID: 22970336]
  22. Science. 1945 Apr 13;101(2624):377 [PMID: 17780321]

Grants

  1. B9RJXO/Wellcome Trust

MeSH Term

Female
Humans
Infant
Malaria, Vivax
Male
Mosquito Control
Pregnancy
Secondary Prevention

Word Cloud

Created with Highcharts 10.0.0vivaxmalariaPlasmodiumpreventioncausedyearsinfectiondangerousrealthreateninginfectiousbitevectorcontrolpreventingmanydifficultemphasizesdifficultymaxim'anounceworthpoundcure'findsbetterdemonstrationsThoroughlyneglectedpast60chemotherapycomplexineffectivepresentWorklastdoneseeingtranslateimprovementsperipherycaredeliverywilltakedeliberateeffortmeantimepatientsfacesubstantialriskdebilitatingfatalcoursesillnessassociateddiagnosisvulnerableoutcomes--pregnantwomeninfants--repeatedattacksacutesingleanophelinenowpreventableOnemeasurescanimmediatelyappliedrigortherebyeffectivelyinfectionspossiblecommentarydireconsequencesPdealingturnbenefitsderivedfirstplaceMalariavivax:recurrenttreatdisablinglife--thepreemptshazardstherapyseverity

Similar Articles

Cited By